Albuvirtide (Aikening®) has been added to the interaction checker on the website and is available via an update on the iChart app.
Albuvirtide is a long acting fusion inhibitor and has marketing approval in China for the treatment of HIV. Albuvirtide is administered once weekly by intravenous infusion.
